Ablation of the mitophagy mediator PINK1 has been shown to induce lipid accumulation and trigger liver steatosis in preclinical models [45], which could be a strategy for balancing metabolic homeostasis, protecting or halting NAFLD. The gene discussed is PINK1; the disease is metabolic dysfunction-associated steatotic liver disease.